SYMPTOMATIC PARKINSON DISEASE
Clinical trials for SYMPTOMATIC PARKINSON DISEASE explained in plain language.
Never miss a new study
Get alerted when new SYMPTOMATIC PARKINSON DISEASE trials appear
Sign up with your email to follow new studies for SYMPTOMATIC PARKINSON DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common pill slow Parkinson's before symptoms appear?
Disease control OngoingThis study is testing whether a medication called terazosin, already approved for blood pressure and prostate issues, can slow the progression of Parkinson's disease in people at high risk. Researchers are enrolling 15 participants who have a sleep disorder linked to Parkinson's …
Matched conditions: SYMPTOMATIC PARKINSON DISEASE
Phase: PHASE2 • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Apr 02, 2026 04:11 UTC
-
Blood pressure drug shows promise in slowing Parkinson's
Disease control OngoingThis study is testing whether terazosin, a medication typically used for high blood pressure, can slow the progression of Parkinson's disease in people at high risk. Researchers will follow 15 participants with early warning signs for three years, using brain and heart scans to t…
Matched conditions: SYMPTOMATIC PARKINSON DISEASE
Phase: PHASE2 • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Heart drug tested to halt Parkinson's before symptoms start
Disease control OngoingThis study is testing whether a medication called carvedilol, commonly used for heart conditions and high blood pressure, can slow down the brain changes that lead to Parkinson's disease. It involves 15 people who are at high risk for Parkinson's because they have a specific slee…
Matched conditions: SYMPTOMATIC PARKINSON DISEASE
Phase: PHASE2 • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Heart drug trial aims to halt Parkinson's before symptoms start
Disease control OngoingThis study is testing if a common heart medication, carvedilol, can slow or prevent the progression of Parkinson's disease in people at high risk. It focuses on individuals with a specific sleep disorder (REM sleep behavior disorder) and other early warning signs. Researchers wil…
Matched conditions: SYMPTOMATIC PARKINSON DISEASE
Phase: PHASE2 • Sponsor: Michele Tagliati, MD • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC